Cas:17622-46-7 4-Ethyl-3,4-dimethyl-2-cyclohexen-1-one manufacturer & supplier

We serve Chemical Name:4-Ethyl-3,4-dimethyl-2-cyclohexen-1-one CAS:17622-46-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Ethyl-3,4-dimethyl-2-cyclohexen-1-one

Chemical Name:4-Ethyl-3,4-dimethyl-2-cyclohexen-1-one
CAS.NO:17622-46-7
Synonyms:4-Ethyl-3,4-dimethyl-2-cyclohexen-1-one
Molecular Formula:C10H16O
Molecular Weight:152
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-Ethyl-3,4-dimethyl-2-cyclohexen-1-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Ethyl-3,4-dimethyl-2-cyclohexen-1-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Ethyl-3,4-dimethyl-2-cyclohexen-1-one Use and application,4-Ethyl-3,4-dimethyl-2-cyclohexen-1-one technical grade,usp/ep/jp grade.


Related News: Setting up of these plants will make the country self-reliant to a large extent in respect of these bulk drugs, it noted. tetracarbonyl(sym-o-anisylthiourea)diiodotungsten(0) manufacturers A CDMO must have bolt-on capabilities with efficient chemistry which translates into adding new capabilities that the specific molecule development may require quickly. 3-(2,2-Dimethyl-1-phenyl-propylcarbamoyl)-1,1-dimethyl-piperidinium; bromide suppliers Zynteglo was granted conditional marketing authorisation in May 2019. The conditional authorisation means that there is more evidence to come about the medicine, which the company will provide. EMA regularly reviews new information that becomes available. 4-(2-bromo-5-methoxybenzyl)-1-(4-(trifluoromethyl)phenethyl)piperidine vendor & factory Zynteglo was granted conditional marketing authorisation in May 2019. The conditional authorisation means that there is more evidence to come about the medicine, which the company will provide. EMA regularly reviews new information that becomes available.,As for the expansion itself, Takeda will build a new 15,000-square-foot manufacturing facility at the site and expand an existing 14,000-square-feet of production space. Takeda has been knocking around the Thousand Oaks area since 1996, the Business Times said.